Results 131 to 140 of about 1,162 (153)

A Retrospective Analysis of Long‐Term Use of Nondepolarizing Neuromuscular Blocking Agents in the Intensive Care Unit, and Guidelines for Drug Selection

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1993
Nondepolarizing neuromuscular blocking agents (NNMBAs) are frequently administered to patients in the intensive care unit (ICU). We conducted a retrospective study of patients in intensive care who received infusions (>48 hrs) of commonly used NNMBAs. The goals were to describe NNMBA use in our ICUs, determine patient characteristics, and assess the
Diann M. Ciarens, Karl J. Kelly, Susan S. Gilliland, Philip K. Kohls, Avi Nahum, Kyle Vance‐Bryan   +5 more
  +5 more sources

Intraoperative Use of Nondepolarizing Neuromuscular Blocking Agents During Cardiac Surgery and Postoperative Pulmonary Complications: A Prospective Randomized Trial

Journal of Cardiothoracic and Vascular Anesthesia, 2018
Nondepolarizing neuromuscular blocking agents (NMBAs) are associated with perioperative complications in noncardiac surgery; however, little is known about their effect on cardiac surgery. This study assessed the effect of neuromuscular blockade (NMB) on the incidence of postoperative pulmonary complications (PPCs) after cardiac surgery and operating ...
Rebecca M. Gerlach, Sajid Shahul, Kristen Wroblewski, Elizabeth K. Cotter, Blake W. Perkins, John-Henry Harrison, Takeyoshi Ota, Valluvan Jeevanandam, Mark A. Chaney   +8 more
openalex   +4 more sources

Long-acting nondepolarizing neuromuscular blocking agents.

AANA journal, 1993
Patients with compromised cardiovascular function who are undergoing cardiothoracic or other lengthy surgical procedures are at risk of complications from the hemodynamic effects of the long-acting nondepolarizing neuromuscular blocking agents (NMBs), which have been in use for several decades.
Embree Pb
openalex   +2 more sources

The pharmacology of GW280430A: A new nondepolarizing neuromuscular blocking agent

Seminars in Anesthesia, Perioperative Medicine and Pain, 2002
Cynthia A. Lien
openalex   +3 more sources

Factors Affecting Administration of Nondepolarizing Neuromuscular Blocking Agents

ASA Refresher Courses in Anesthesiology, 1980
Jay Ham
openalex   +3 more sources

Use of nondepolarizing neuromuscular blocking agents in mechanically ventilated patients.

Clinical pharmacy, 1991
The pharmacology and history of development of nondepolarizing neuromuscular blocking agents are presented, and the pharmacokinetics and pharmacodynamics of these agents, administration guidelines for mechanically ventilated patients, adverse effects, factors affecting paralysis, and methods for blockade reversal are reviewed.
Marcia L. Buck, Michael D. Reed
openalex   +2 more sources

A862 G1–64, A NEW, RAPIDLY ACTING NONDEPOLARIZING NEUROMUSCULAR BLOCKING AGENT

Anesthesiology, 1990
Laszlo Gyermek, Nam C. Nguyen, C. Lee
openalex   +3 more sources

Effects of nondepolarizing neuromuscular blocking agents on erythrocytes in vitro

American Journal of Health-System Pharmacy, 1984
Demitri A. Cozanitis
openalex   +4 more sources

THE PHARMACOLOGY OF NEW SHORT-ACTING NONDEPOLARIZING ESTER NEUROMUSCULAR BLOCKING AGENTS

Survey of Anesthesiology, 1974
J. J. SAVARESE, S. Ginsburg, Chingmuh Lee, Richard J. Kitz   +3 more
openalex   +4 more sources

Can previously injected botulinum toxin cause paradoxical masseter muscle rigidity after administration of a nondepolarizing neuromuscular blocking agent?

Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 2023
Ji Young Lee, Kwon Hui Seo
openalex   +3 more sources